Literature DB >> 9653654

Cloning and characterization of the full-length cDNA and genomic sequences encoding murine acid ceramidase.

C M Li1, S B Hong, G Kopal, X He, T Linke, W S Hou, J Koch, S Gatt, K Sandhoff, E H Schuchman.   

Abstract

The full-length cDNA and genomic sequences encoding murine acid ceramidase (AC; E.C. 3.5.1.23) have been isolated and characterized. The 2176-bp cDNA was approximately 80% identical to the human cDNA (Koch et al., 1996) and predicted a 394-amino-acid polypeptide that was approximately 90% identical to the human protein. A fluorescence-based assay system was developed to determine AC enzymatic activity, and transfection of COS-1 cells with the full-length mouse cDNA led to increased AC activity, demonstrating its functionality. The murine AC gene, which spanned approximately 38 kb, consisted of 14 exons separated by 13 introns. The exons ranged in size from 46 to 1038 bp and were flanked by exon/intron junctions that adhered closely to known donor and acceptor splice site consensus sequences. Exon 1 encoded the putative translation start site and the signal peptide region, while exon 14 encoded the carboxy end of the AC polypeptide and all of the 3' untranslated region. Sequence analysis of a 497-bp region upstream from the first in-frame ATG revealed several features of a housekeeping promoter, as well as several tissue-specific and/or hormone-inducible regulatory sites. Insertion of this sequence into a chloramphenicol acyltransferase (CAT) expression vector led an approximately fivefold increase in CAT activity after transfection into NIH3T3 cells. Northern blot analysis and enzymatic assays also were carried out on various murine tissues to examine AC expression. Of the tissues studied, the highest AC activity and mRNA levels were found in the kidney, followed by the brain; almost no AC activity or mRNA was found in the testis or skeletal muscle. These latter studies provided clear evidence that despite the housekeeping function of AC, its expression was tissue-specific.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9653654     DOI: 10.1006/geno.1998.5334

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  32 in total

1.  Cloning and characterization of a wheat neutral ceramidase gene Ta-CDase.

Authors:  Xiumei Yu; Xiaojie Wang; Xueling Huang; Heinrich Buchenauer; Qingmei Han; Jun Guo; Jie Zhao; Zhipeng Qu; Lili Huang; Zhensheng Kang
Journal:  Mol Biol Rep       Date:  2010-11-19       Impact factor: 2.316

2.  Genistein stimulates MCF-7 breast cancer cell growth by inducing acid ceramidase (ASAH1) gene expression.

Authors:  Natasha C Lucki; Marion B Sewer
Journal:  J Biol Chem       Date:  2011-04-14       Impact factor: 5.157

Review 3.  Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.

Authors:  Daniel Canals; David M Perry; Russell W Jenkins; Yusuf A Hannun
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 4.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

5.  Degradation of glycosphingolipids in oyster: ceramide glycanase and ceramidase in the hepatopancreas of oyster, Crassostrea virginica.

Authors:  Nadejda V Pavlova; Su-Chen Li; Yu-Teh Li
Journal:  Glycoconj J       Date:  2017-10-16       Impact factor: 2.916

6.  The cAMP-responsive element binding protein (CREB) regulates the expression of acid ceramidase (ASAH1) in H295R human adrenocortical cells.

Authors:  Natasha Lucki; Marion B Sewer
Journal:  Biochim Biophys Acta       Date:  2009-03-16

7.  Potent inhibition of Acid ceramidase by novel B-13 analogues.

Authors:  Denny Proksch; Jan Jasper Klein; Christoph Arenz
Journal:  J Lipids       Date:  2010-12-09

Review 8.  Molecular targeting of acid ceramidase: implications to cancer therapy.

Authors:  Youssef H Zeidan; Russell W Jenkins; John B Korman; Xiang Liu; Lina M Obeid; James S Norris; Yusuf A Hannun
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

9.  Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide.

Authors:  Marcin Baranowski; Agnieszka Blachnio-Zabielska; Tomasz Hirnle; Dorota Harasiuk; Krzysztof Matlak; Malgorzata Knapp; Piotr Zabielski; Jan Gorski
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

10.  A neutral ceramidase homologue from Dictyostelium discoideum exhibits an acidic pH optimum.

Authors:  Hatsumi Monjusho; Nozomu Okino; Motohiro Tani; Mineko Maeda; Motonobu Yoshida; Makoto Ito
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.